Literature DB >> 2029791

Cell-free supernatants of sarcoid alveolar macrophages suppress proliferation of sarcoid alveolar fibroblasts.

E Fireman1, S Ben Efraim, G Messer, S Dabush, J Greif, M Topilsky.   

Abstract

We have reported that alveolar macrophages (AM) isolated from sarcoidosis (SA) patients, as well as cell-free supernatants of these macrophages, markedly suppressed mitogenic stimulation of peripheral blood lymphocyte (PBL). We now show that cell-free supernatants of AM originating from sarcoidosis patients also suppress [3H]thymidine incorporation by fibroblast (Fb) cultures resulting from bronchoalveolar lavages (BAL) of SA: 40.6% inhibition compared with only 8.2% by supernatants of AM obtained from nonsarcoid controls. The clones of proliferating Fb appeared in cultures of BAL cells after most of the macrophages were detached from the tissue culture surface and actively synthesized collagen, as demonstrated by ultrastructural studies. In confirmation with previously reported results, the same supernatants from AM of SA patients also suppressed mitogenic stimulation of PBL (35.7% inhibition of [3H]thymidine incorporation compared with only 16.3% inhibition by control supernatants). They also contained high amounts of IL-1 (178 compared to 9.2 U/ml of control supernatants), whereas the PGE2 content was within normal levels (0.28 compared to 0.19 ng/ml/10(5) cells in control supernatants). It is concluded that AM from SA patients release a factor(s) which suppresses the proliferation of alveolar fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2029791     DOI: 10.1016/0090-1229(91)90032-6

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  5 in total

1.  Constitutive activation of prosurvival signaling in alveolar mesenchymal cells isolated from patients with nonresolving acute respiratory distress syndrome.

Authors:  Jeffrey C Horowitz; Zongbin Cui; Thomas A Moore; Tamara R Meier; Raju C Reddy; Galen B Toews; Theodore J Standiford; Victor J Thannickal
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-10-07       Impact factor: 5.464

2.  Effect of montelukast, a cysteinyl receptor antagonist, on myofibroblasts in interstitial lung disease.

Authors:  Elizabeth Fireman; Yehuda Schwartz; Abraham Mann; Joel Greif
Journal:  J Clin Immunol       Date:  2004-07       Impact factor: 8.317

3.  Preface.

Authors:  P L Giorgi; N Oggiano; A Kantar; A Corrias
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

4.  Bronchoalveolar-Lavage-Derived Fibroblast Cell Lines Provide Tools for Investigating Various Interstitial Lung Diseases.

Authors:  Siri Lehtonen; Riitta Kaarteenaho
Journal:  Cells       Date:  2022-07-18       Impact factor: 7.666

5.  Suppressive effect of TNF-alpha and IL-1 on alveolar fibroblast proliferation in sarcoidosis.

Authors:  E Fireman; D Aderka; S B Efraim; J Greif; D Wallach; M Topilsky
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.